PRODUCTION OF PERTUSSIS TOXIN BY BORDETELLA PERTUSSIS STRAINS ISOLATED FROM PATIENTS WITH WHOOPING COUGH


Cite item

Full Text

Abstract

Aim. To assess level of pertussin toxin (PT) production by vaccine strains of Bordetella pertussis and strains isolated from patients with whooping cough. Materials and methods. Concentration of PT in supernatants of microbial cultures of 3 vaccine strains and 25 strains of B.pertussis isolated from patients with pertussis in 2001—2005 was measured with enzyme immunoassay using gamma-globulin fractions of rabbit antiserum to PT as immunosorbent or included in peroxidase conjugates. Results. Level of PT production by strains isolated from infected persons varied from 3±0.5 to 64.8±12.2 ng/MFU/ml: in 9 strains — from 3±0.5 to 9.4±2.1 ng/MFU/ml, in 7 — 10.5±1.8 to 18.4±2.6 ng/MFU/ml, and in 9 — 23.6±4.5 to 64.8±12.2 ng/MFU/ml. Conclusion. B.pertussis strains isolated from patients were heterogeneous on level of PT production. Difference in expression of PT between strains were as high as 20-fold. Conditionally low, moderate and high levels of PT production had 9 (36%), 7 (28%), and 9 (36%) of 25 studied strains. Three vaccine strains had levels of toxin production similar to recently isolated strains with moderate level of its production.

Full Text

ПРОДУКЦИЯ КОКЛЮШНОГО ТОКСИНА ВЫДЕЛЕННЫМИ ОТ БОЛЬНЫХ КОКЛЮШЕМ ШТАММАМИ BORDETELLA PERTUSSIS
×

About the authors

E. M Zaitsev

Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia

N. U Mertsalova

Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia

A. S Shinkarev

Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia

I. K Mazurova

Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology, Moscow, Russia

N. S Zakharova

Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia

References

  1. Захарова Н.С., Брицина М.В., Мерцалова Н.У. и др. Отечественная бесклеточная вакцина. Журн. микробиол. 2008, 1: 35-41.
  2. Смирнов В.Д., Максютов Р.В., Эглит Ю.Х. и др. Разработка метода количественного определения токсина коклюшных бактерий и перспектива его использования для диагностики. Там же. 1989, 2: 103-107.
  3. Bouches V., Brun D., Cantinelli T. et al. First report and detailed characterization of B. perussis isolates non exspressing pertussius toxin or pertactin. Vaccine. 2009, 27 (43): 6034-6041.
  4. Kallonen T., He Q. Bordetella pertussis strain variation and evolution postvaccination. Expert. Rev. Vac. 2009, 8 (7): 863-875.
  5. Letowska I., Chodorowska M., Kaczurba E. et al. Bacteria growth and virulence factors production by different Bordetella pertussis strains. Acta Microiol. Pol.1977, (46)1:45-55.
  6. Locht C. Molecular aspects of Bordetella pertussis pathogenesis. Int. Microbiol.1999, 2 (30): 137-144.
  7. Mooi F.R., van Loo I.H., van Gent M. et al. Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg. Infect. Dis. 2009, 15 (8): 1206-1213.
  8. Thalen M., Venema M., van den Ijssel J. et al. Effect of relevant culture parameters on рertussis toxin exspression by Bordetella pertussis. Biologicals. 2006, 34 (3): 213-220.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2011 Zaitsev E.M., Mertsalova N.U., Shinkarev A.S., Mazurova I.K., Zakharova N.S.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС77-75442 от 01.04.2019 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies